Once per week, subcutaneously, on the same day each week
Moreover, for people already dealing with substance abuse, it decreased adverse events and the risk of death by 50%.[ref] Which GLP-1 Agonists are Approved for Weight Loss
Recent findings indicate that the anti-inflammatory effects of GLP-1RAs, mediated through GLP-1R in CNS neurons (268) and intrahepatic lymphocytes (269), play an important role in their antiatherogenic actions
Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, et al
Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction
Mechanisms of statin-induced new-onset diabetes